Mental Health

The treatment could hold significant potential for major depressive disorder

With Oregon, Colorado, and New Mexico legalizing psilocybin-assisted therapy, opportunities for treatment are expanding.

These findings demonstrate an association that is independent of the disease’s genetic predisposition.

These results build off prior studies which demonstrated effectiveness of Bergen 4-day treatment (B4DT) in patients with panic disorders.

A recent study reveals a significant number of patients with psychiatric histories experience emergency visits after starting glucagon-like peptide-1 (GLP-1) medications, raising safety concerns.

New research highlights the need for evidence-based buspirone use in psychiatric settings, revealing high off-label prescriptions and suboptimal dosing practices.

Pharmacists can perform MTM consultations and provide clinical recommendations to the health care team.

Because mothers are already at risk of depression postpartum, health care professionals must properly counsel mothers on hormonal contraceptives.

This movement has aimed to address the mental health care epidemic in the United States.

Reducing stigma, improving mental health benefits, and addressing workload concerns all need to happen simultaneously.

Schizophrenia is a chronic mental illness that significantly affects patients through its symptoms, associated health conditions, and treatment challenges, with long-acting injectable antipsychotics offering potential benefits in improving adherence and reducing relapses.

About 59.2% of patients with tardive dyskinesia (TD) who completed the 48-week trial achieved remission.

The move is expected to expand clozapine access for patients with schizophrenia.

Research has demonstrated a reduction in hospitalization risk associated with the use of LAIs, but some barriers can prevent the wider adoption of this approach.

The authors suggest future research should consider inflammation and the gut as potential therapeutic targets improve depression in patients with chronic kidney disease (CKD).

Pharmacists can provide resources, monitor medications, and extend compassionate support to patients experiencing mental health challenge.

Vietnam war trauma continues to affect veterans’ health 50 years later.

In the phase 3 CONNEX clinical trial program, iclepertin did not meet its primary and secondary end points.

The demands of the pharmacy profession—long hours, high stress, and emotional strain—can take a toll on pharmacists’ well-being.

Pregnant individuals with multiple sclerosis (MS) are more likely to experience mental illness both during their pregnancy and in the first years after giving birth.

Despite these findings, navacaprant was generally well-tolerated and safe in patients with major depressive disorder.

The study found that internalizing and externalizing factors, brain maturation, and decreasing volumes of brain regions were linked to eating disorders.

Esketamine targets glutamate, the most abundant neurotransmitters in the brain.

The authors note that future research will observe personality changes when psilocybin is used in patients with opioid-use disorder.

Posttraumatic stress disorder is found to be associated with coronary artery disease, hypertension, and heart failure.

The rising use of prescription stimulants in the US presents significant safety risks, legal challenges, and supply chain shortages, emphasizing the need for pharmacist involvement in promoting responsible prescribing.

COVID-19 survivors deemed the most highly impacted and fearful also reported the lowest health-related quality of life scores, indicating an association.

Female adolescents were at an increased risk of experiencing depression and anxiety symptoms compared with males.

The findings show a need for researchers and health care professionals to consider model designs to minimize disparities when diagnosing perinatal mood and anxiety disorders (PMADs).